US Patent Issued to Alkahest on Dec. 16 for "Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases" (California Inventors)

ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,296, issued on Dec. 16, was assigned to Alkahest Inc. (San Carlos, Calif.).

"Benzodioxane modulators of leukotriene A4 hydrolase (LTA4H) for prevention and treatment of aging-associated diseases" was invented by Meghan Kerrisk Campbell (San Francisco), Eva Czirr (Foster City, Calif.) and Reema Harish (Redwood City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention pertains to the prevention and treatment of aging-associated disease. The invention relates to the use of benzodioxane inhibitors of leukotriene production through modulation of leukotriene A4 hydrolase ("LTA4H") to treat and/or prevent conditions associated with aging s...